Friday, November 27, 2020

FedNet

Multimedia News Content Leader in Washington since 1996

Contact FedNet to purchase a verbatim transcript

Pharmaceutical Executives on Drug Prices

House Oversight and Reform Committee

Unsustainable Drug Prices: Testimony from the CEOs (Part II)

Thursday October 1, 2020 10:00 a.m.

Room: 2154 Rayburn Bldg.

Mr. Robert Bradway, Chairman and Chief Executive Officer, Amgen Inc.

Mr. Thomas Kendris, U.S. Country President, Novartis AG

Mr. Mark Trudeau, President and Chief Executive Officer, Mallinckrodt Pharmaceuticals